Pricing Log in Create free account

Kodiak Sciences Inc. (KOD) vs Rhythm Pharmaceuticals, Inc. (RYTM)

Kodiak Sciences Inc. and Rhythm Pharmaceuticals, Inc. are both Biotechnology companies. Kodiak Sciences Inc. and Rhythm Pharmaceuticals, Inc. are of similar size ($6.1B and $5.5B). Kodiak Sciences Inc. has the higher net margin (0.00% vs −87.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Rhythm Pharmaceuticals, Inc. leads on 7 and Kodiak Sciences Inc. on 5.

Valuation

Metric KOD RYTM Biotechnology median
P/E n/m n/m 8.50
P/S n/m 24.64 9.71
P/B 87.90 57.39 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 23.26 9.21
Earnings yield (4.89%) (3.61%) (33.15%)
Free cash flow yield (2.98%) (2.55%) (25.50%)

Profitability

Metric KOD RYTM Biotechnology median
Gross margin 0.00% 89.00% 65.16%
Operating margin 0.00% (83.62%) 0.00%
Net margin 0.00% (87.62%) 0.00%
Free cash flow margin 0.00% (43.91%) 0.00%
Return on equity (368.37%) (461.65%) (56.36%)
Return on assets (94.25%) (51.91%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KOD RYTM Biotechnology median
Revenue growth (TTM) — 53.51% 6.02%
EPS growth (last fiscal year) (28.96%) 28.34% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KOD RYTM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.49 3.45 4.72
Net debt to EBITDA 1.01 2.04 0.96

Dividend

Metric KOD RYTM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KOD RYTM Biotechnology median
Market cap 5.54b 6.06b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack